111 related articles for article (PubMed ID: 1695018)
21. Simultaneous evaluation of intestinal absorption and hepatic extraction of 5-fluorouracil using portal-systemic concentration difference by short-period double dosing in a single conscious rat.
Sawai Y; Yamaoka K; Ito T; Nakagawa T
Biol Pharm Bull; 1997 Dec; 20(12):1313-6. PubMed ID: 9448112
[TBL] [Abstract][Full Text] [Related]
22. Nucleotide profile in rat liver and intestine at portal vein obstruction and reflow.
Jakobsson B; el Hag IA; Stenram U
Biomed Biochim Acta; 1991; 50(8):1001-6. PubMed ID: 1781771
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of 5-fluorouracil following hepatic intra-arterial infusion in a VX2 hepatic metastasis model.
Sadahiro S; Suzuki T; Ishikawa K; Tanaka Y; Masuda T; Nakamura T; Yasuda S; Makuuchi H; Murayama C
Jpn J Clin Oncol; 2003 Aug; 33(8):377-81. PubMed ID: 14523056
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of 5-fluorouracil following different routes of intrahepatic administration in the canine model.
Didolkar MS; Covell DG; Jackson AJ; Walker AP; Kalidindi SR
Cancer Res; 1984 Nov; 44(11):5105-9. PubMed ID: 6488170
[TBL] [Abstract][Full Text] [Related]
25. The influence of degradable starch microspheres on liver uptake of 5-fluorouracil after hepatic artery injection in the rat.
Teder H; Aronsen KF; Björkman S; Lindell B; Ljungberg J
J Pharm Pharmacol; 1986 Dec; 38(12):939-41. PubMed ID: 2880975
[TBL] [Abstract][Full Text] [Related]
26. Increased therapeutic effect on metastatic liver tumors in rats of two-route chemotherapy using cis-diamminedichloroplatinum (II) and its antidote, sodium thiosulfate, with temporary clamping of the abdominal aorta.
Hasuda K; Kobayashi H; Aoki K; Taniguchi S; Baba T
Cancer Chemother Pharmacol; 1990; 26(3):181-7. PubMed ID: 2357764
[TBL] [Abstract][Full Text] [Related]
27. [Preliminary observation on hepatic arterial infusion under temporary hepatic circulation occlusion in rabbits].
Liu X; Xiong L; Xu R; Cao X
Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):91-4. PubMed ID: 25975683
[TBL] [Abstract][Full Text] [Related]
28. Effect of hepatic artery ligation on the incorporation of 3H-orotic acid into an adenocarcinoma transplanted to rat liver.
Erichsen C; Christensson PI; Jönsson PE; Stenram U
Eur J Surg Oncol; 1986 Jun; 12(2):181-6. PubMed ID: 2423375
[TBL] [Abstract][Full Text] [Related]
29. Cardio-pulmonary elimination of 5-fluorouracil after bolus injection in the hepatic artery.
Andersson M; Billström A; Domellöf L; Gustavsson B
Eur J Surg Oncol; 1987 Feb; 13(1):35-9. PubMed ID: 3028867
[TBL] [Abstract][Full Text] [Related]
30. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
Myers CE; Young RC; Chabner BA
Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826
[TBL] [Abstract][Full Text] [Related]
31. Influence of the routes of continuous intrahepatic infusion of 5-fluorouracil on its pharmacokinetics.
Didolkar MS; Jackson AJ; Covell DG; Walker AP; Eddington ND
J Surg Oncol; 1989 Jul; 41(3):187-93. PubMed ID: 2747244
[TBL] [Abstract][Full Text] [Related]
32. Regional pharmacokinetics of 5-bromo-2'-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions.
Kuan HY; Smith DE; Ensmiger WD; Knol JA; DeRemer SJ; Yang Z; Stetson PL
Cancer Res; 1996 Oct; 56(20):4724-7. PubMed ID: 8840990
[TBL] [Abstract][Full Text] [Related]
33. [In vivo comparative study of the pharmacokinetics of chemotherapeutic agents infused via hepatic artery or portal vein against hepatic metastases. DRC Group].
Naomoto Y; Gochi A; Hizuta A; Iwagaki H; Matsuno T; Hamazaki K; Tanaka N; Orita K
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1555-8. PubMed ID: 8373217
[TBL] [Abstract][Full Text] [Related]
34. Increased uptake of 5-FU in experimental liver tumours by simultaneous infusion of norepinephrine.
Vagianos C; Puntis M; Jeppsson B; Steen S; Zoucas E; Bengmark S
Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1323-7. PubMed ID: 3678326
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of capacity-limited first-pass effect through liver by three-points sampling in portal and hepatic veins and systemic artery.
Ueda S; Yamaoka K; Yui J; Shigematsu A; Nakagawa T
Pharm Res; 2002 Jun; 19(6):852-7. PubMed ID: 12134957
[TBL] [Abstract][Full Text] [Related]
36. [Pharmacokinetic studies on continuous intraportal 5-fluorouracil infusion].
Matsuzaki H; Yamamura T; Hanai A; Oikawa H; Kikuchi K; Seo K; Ozasa T; Akaishi O; Tsukikawa S; Yamaguchi S
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2121-3. PubMed ID: 7944418
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of 5-fluorouracil by the liver during continuous regional and systemic infusion in pigs.
Almersjö O; Brandberg A; Gustavsson B; Hafström LO; Seeman T
Eur Surg Res; 1976; 8(6):489-96. PubMed ID: 1017433
[TBL] [Abstract][Full Text] [Related]
38. Regional chemotherapy in the canine liver.
Zografos GC; Kanter P; Sharma SD; Driscoll DL; Blumenson LE; Karakousis CP
J Surg Oncol; 1994 Jun; 56(2):113-5. PubMed ID: 8007676
[TBL] [Abstract][Full Text] [Related]
39. [31P-NMR study on the high energy phosphate metabolism in warm ischemic rat liver caused by hepatic artery and portal vein occlusion].
Kokudo Y; Maeba T; Tanaka S
Nihon Shokakibyo Gakkai Zasshi; 1991 Mar; 88(3):698-705. PubMed ID: 2046151
[TBL] [Abstract][Full Text] [Related]
40. [An experimental study on portal infusion of 5-fluorouracil (the second report)].
Ishida H; Iwama T; Ide A; Nihei Z; Imajo M; Mishima Y
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1532-5. PubMed ID: 1530301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
